Pharma Journalist 8947 posts 0 comments

Pascal Biosciences Inc. and Y-Biologics announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia.…
Read More...

ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system…
Read More...

Cyclo Therapeutics, Inc., a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease,…
Read More...

Boehringer Ingelheim presented promising preclinical data from its pan-KRAS program including the novel, oral inhibitor BI 1701963 at the AACR-NCI-EORTC International Conference on…
Read More...

Themis Bioscience and CEPI – the Coalition for Epidemic Preparedness Innovations – announced the first administration to healthy volunteers in a Phase 1 clinical trial with Themis’…
Read More...

The European Commission (EC) approved a new indication for Dupixent (dupilumab) in chronic rhinosinusitis with nasal polyposis (CRSwNP). Dupixent is indicated as an add-on therapy with…
Read More...

During the 2019 edition of the PREDiCT: 3D Tissue Models Summit, we caught up with StemoniX ahead of their presentation to gain insight on their current work and future projects!…
Read More...

Enesi Pharma, the innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, is delighted to announce that it has been awarded grant funding…
Read More...

SMi has released an exclusive interview with industry expert Che Connon, Professor of Tissue Engineering at Newcastle University, ahead of the upcoming Ophthalmic Drugs conference which…
Read More...

SMi Reports: A Focus Day has been added to SMi’s RNA Therapeutics Conference, which will highlight the recent developments in "Oligonucleotide Delivery Systems." SMi Group are proud to…
Read More...